Results
73,160 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Derhacobian NarbehDirector |  LTRXLANTRONIX INCOption exercise | M | — 8,541 sh | Nov 4, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Derhacobian NarbehDirector | LTRXLANTRONIX INC Option exercise | M | — 8,541 sh | Nov 4, 2026 |
| 13 | Jordan Joseph HughDirector, Chief Executive Officer |  DPZDOMINOS PIZZA INCOption exercise · 10b5-1 plan | M | $819K 4,870 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Rubin ElaineDirector |  DXLGDESTINATION XL GROUP, INC.Grant or award | A | $18K 40.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Chemodurow TanyaDirector |  EBMTEagle Bancorp Montana, Inc.Grant or award | A | — 1,232 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Sheena JonathanDirector, CO-FOUNDER |  NTRANatera, Inc.Open-market sale · 10b5-1 plan | SELL | $1,165 3 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Sheena JonathanDirector, CO-FOUNDER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $44K 109 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Stiefel Justin BDirector, CEO & Treasurer |  IPSTIP STRATEGY HOLDINGS, INC.Tax withholding | F | $961 433 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Clark LauraDirector, CEO | EBMTEagle Bancorp Montana, Inc. Grant or award | A | — 4,333 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 13 | Piazza Nicholas J.Senior VP & CPO |  EMREMERSON ELECTRIC COGrant or award | A | — 12.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director |  SUPNSUPERNUS PHARMACEUTICALS, INC.Other acquisition or disposition | J | — 7,905 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,989 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 25.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 85.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Bhatt Padmanabh P.Sr. VP of IP, CSO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,036 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 13.5K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 40.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,847 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 1.26M sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 400.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,375 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Sloan Lindsay LVP & Chief Accounting Officer |  CMCCOMMERCIAL METALS CoGift | G | — 200 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,293 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 20.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 20.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 70.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Ring ChristineChief Legal Officer |  NRIXNurix Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $29K 1,075 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 281.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barker BrianDirector |  ACUACME UNITED CORPOption exercise | M | $109K 5,000 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Coghlan John PhilipDirector |  LIFLife360, Inc.Open-market sale · 10b5-1 plan | SELL | $66K 1,433 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 8,252 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 25.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 14.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | O'Connor Brad GCFO |  HOVHOVNANIAN ENTERPRISES INCTax withholding | F | $117K 1,116 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Coghlan John PhilipDirector | LIFLife360, Inc. Open-market sale · 10b5-1 plan | SELL | $83K 1,841 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Sorsby J LarryDirector | HOVHOVNANIAN ENTERPRISES INC Tax withholding | F | $193K 1,842 sh | Nov 4, 2026 traded Nov 2, 2026 |